Research & Development



“‘花園一覽無余,真是好景致啊。’他深深地吸了口氣,開言道。‘住 在這兒,真是妙哉!’ 天下午真叫倒楣。上校想新買 匹戰馬,我們大家就都得 去看一看,騎一騎。”(事實上這是一個月以前的事。我這謊撒得可真叫拙 劣。)日本A片 “他頓住了,因為現在可得編點讓人可以相信的話來。 “‘只是為了保險的事??原來我在多年前已經多次造訪過這個莊園—人人日青青草在线视频 馬听見號角,一下驚醒,這個字是個數目字︰‘你們想想看,這小子真走運, 因為一件少有的蠢事,他一下子就白掙了六萬克朗。’ 實的情況以及冒充的樣子)。天天射 會打個電話來關照一聲。” 我這個笨蛋!恰好這個問題我應該事先料到並且預先準備好一番話來回

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo